Rifampicin in periprosthetic joint infections: where do we stand and where are we headed?

Expert Rev Anti Infect Ther

Department of infectious diseases, Leiden University Medical Center, University of Leiden, Leiden, The Netherlands.

Published: June 2023

AI Article Synopsis

  • Periprosthetic joint infections (PJI) are serious complications following joint replacement surgeries and require surgical intervention and long-term antibiotic therapy.
  • Rifampicin is a key antibiotic for treating staphylococcal PJI, but its specific roles and guidelines for use in various situations are still unclear.
  • The article summarizes current research on rifampicin's effectiveness, identifies issues regarding its usage, and emphasizes the need for more randomized controlled trials to clarify its clinical applications.

Article Abstract

Introduction: A periprosthetic joint infection (PJI) is a major complication of arthroplasty. Treatment of PJI consists of surgical debridement with or without the exchange of the implant and long-term antimicrobial treatment. Rifampicin is regarded as one of the cornerstones of antimicrobial treatment for staphylococcal PJI, but the exact role of rifampicin for PJI in different clinical scenarios remains to be elucidated.

Areas Covered: In this perspective article, an overview is provided of in vitro, in vivo and clinical studies that were the basis of the current guidelines and recommendations for rifampicin use in daily practice for PJI. Controversial issues on indication, dosing, timing, duration, and antibiotic drug interactions will be addressed. Finally, the most urgent clinical questions on rifampicin use that need answering in the nearby future will be formulated.

Expert Opinion: Many inquiries remain concerning the exact indications and clinical use of rifampicin in PJI. Randomized controlled trials are needed to answer these questions.

Download full-text PDF

Source
http://dx.doi.org/10.1080/14787210.2023.2211263DOI Listing

Publication Analysis

Top Keywords

periprosthetic joint
8
antimicrobial treatment
8
rifampicin pji
8
rifampicin
6
pji
6
rifampicin periprosthetic
4
joint infections
4
infections stand
4
stand headed?
4
headed? introduction
4

Similar Publications

In total joint arthroplasty, periprosthetic joint infection (PJI) can be devastating. Corticosteroid injections (CSIs) are commonly administered for temporary pain relief in the setting of various conditions. Therefore, the current systematic review aims to evaluate whether CSIs administered prior to total shoulder arthroplasty (TSA) are a risk factor for PJI and revision surgery.

View Article and Find Full Text PDF

Purpose: The Coronavirus Disease 2019 (COVID-19) pandemic delayed elective procedures such as total joint arthroplasty. As surgical volumes return to prepandemic levels, understanding the implications of COVID-19 becomes imperative. This study explored the effects of COVID-19 on the short-term outcomes of hip arthroplasty.

View Article and Find Full Text PDF

The increased prevalence of methicillin-resistant (MRSA) and its biofilms poses a great threat to human health. Especially, -related osteomyelitis was hardly cured even by conventional antibiotics combined with surgical treatment. The development of novel structural antibiotics is urgently needed.

View Article and Find Full Text PDF

Purpose: The study aimed to compare the infection control rates, mechanical complications, and functional outcomes between prosthetic and cement spacers in two-stage revision arthroplasty for chronic periprosthetic joint infection (PJI).

Patients And Methods: Data from patients treated for chronic PJI in our center from 2014 to 2023 were retrospectively collected and the patients were divided into the prosthetic spacer (PS) and cement spacer (CS) groups based on the type of spacer used for the first-stage surgeries. Data on patients' demographics and clinical scores were harvested.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!